Advertisement
U.S. Markets closed

Marker Therapeutics, Inc. (MRKR)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Visitors trend2W10W9M
4.2900+0.5300 (+14.10%)
At close: 04:00PM EST
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
0
0
0
0
466.785
Operating Expense
10,995
14,581
19,791
39,478
28,886
Operating Income
-10,995
-14,581
-19,791
-39,478
-28,419
Net Non Operating Interest Income Expense
691.008
539.158
248.063
5.7
148.742
Other Income Expense
-
-
-232.974
-2,407
31
Pretax Income
-10,304
-14,042
-19,776
-41,879
-28,239
Tax Provision
-
3.675
0
-
-
Net Income Common Stockholders
-10,371
-8,237
-29,931
-41,879
-28,706
Diluted NI Available to Com Stockholders
-10,371
-8,237
-29,931
-41,879
-28,706
Basic EPS
-1.07
-0.94
-3.58
-5.47
-6.10
Diluted EPS
-1.08
-0.94
-3.58
-5.47
-6.10
Basic Average Shares
8,680
8,809
8,351
7,651
4,704
Diluted Average Shares
8,719
8,809
8,351
7,651
4,704
Total Operating Income as Reported
-10,995
-14,581
-19,791
-39,478
-28,886
Total Expenses
10,995
14,581
19,791
39,478
28,886
Net Income from Continuing & Discontinued Operation
-10,371
-8,237
-29,931
-41,879
-28,706
Normalized Income
-10,308
-14,046
-19,776
-41,879
-28,737
Interest Income
691.008
539.158
248.063
5.7
148.742
Net Interest Income
691.008
539.158
248.063
5.7
148.742
EBIT
-10,995
-14,581
-19,791
-39,478
-28,419
EBITDA
-10,995
-14,581
-19,791
-36,315
-27,343
Reconciled Depreciation
-
-
3,680
3,163
1,076
Net Income from Continuing Operation Net Minority Interest
-10,308
-14,046
-19,776
-41,879
-28,706
Total Unusual Items Excluding Goodwill
-
-
-
-
31
Total Unusual Items
-
-
-
-
31
Normalized EBITDA
-10,995
-14,581
-19,791
-36,315
-27,374
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0